159 related articles for article (PubMed ID: 29298796)
21. Integrin αvβ₆-Targeted SPECT Imaging for Pancreatic Cancer Detection.
Liu Z; Liu H; Ma T; Sun X; Shi J; Jia B; Sun Y; Zhan J; Zhang H; Zhu Z; Wang F
J Nucl Med; 2014 Jun; 55(6):989-94. PubMed ID: 24711651
[TBL] [Abstract][Full Text] [Related]
22. Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma.
Müller M; Altmann A; Sauter M; Lindner T; Jäger D; Rathke H; Herold-Mende C; Marmé F; Babich J; Mier W; Haberkorn U
Nuklearmedizin; 2019 Aug; 58(4):309-318. PubMed ID: 31075798
[TBL] [Abstract][Full Text] [Related]
23. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
24. Perspective of αvβ6-Integrin Imaging for Clinical Management of Pancreatic Carcinoma and Its Precursor Lesions.
Steiger K; Schlitter AM; Weichert W; Esposito I; Wester HJ; Notni J
Mol Imaging; 2017 Jan; 16():1536012117709384. PubMed ID: 28627323
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
26. Toward the Clinical Development and Validation of a Thy1-Targeted Ultrasound Contrast Agent for the Early Detection of Pancreatic Ductal Adenocarcinoma.
Bam R; Daryaei I; Abou-Elkacem L; Vilches-Moure JG; Meuillet EJ; Lutz A; Marinelli ER; Unger EC; Gambhir SS; Paulmurugan R
Invest Radiol; 2020 Nov; 55(11):711-721. PubMed ID: 32569010
[TBL] [Abstract][Full Text] [Related]
27. A novel plectin/integrin-targeted bispecific molecular probe for magnetic resonance/near-infrared imaging of pancreatic cancer.
Wang Q; Yan H; Jin Y; Wang Z; Huang W; Qiu J; Kang F; Wang K; Zhao X; Tian J
Biomaterials; 2018 Nov; 183():173-184. PubMed ID: 30172243
[TBL] [Abstract][Full Text] [Related]
28. A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins.
Monieri M; Rainone P; Sacchi A; Gori A; Gasparri AM; Coliva A; Citro A; Ferrara B; Policardi M; Valtorta S; Pocaterra A; Alfano M; Sheppard D; Piemonti L; Moresco RM; Corti A; Curnis F
Int J Biol Sci; 2023; 19(1):156-166. PubMed ID: 36594095
[No Abstract] [Full Text] [Related]
29. Preclinical evaluation of near-infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence-guided surgery.
Saccomano M; Dullin C; Alves F; Napp J
Int J Cancer; 2016 Nov; 139(10):2277-89. PubMed ID: 27428782
[TBL] [Abstract][Full Text] [Related]
30. Intraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A Multicenter Feasibility Dose-Escalation Study.
Mulder BGS; Koller M; Duiker EW; Sarasqueta AF; Burggraaf J; Meijer VE; Vahrmeijer AL; Hoogwater FJH; Bonsing BA; van Dam GM; Mieog JSD; Pranger BK
J Nucl Med; 2023 Jan; 64(1):82-89. PubMed ID: 35680414
[TBL] [Abstract][Full Text] [Related]
31. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
Mace TA; Shakya R; Pitarresi JR; Swanson B; McQuinn CW; Loftus S; Nordquist E; Cruz-Monserrate Z; Yu L; Young G; Zhong X; Zimmers TA; Ostrowski MC; Ludwig T; Bloomston M; Bekaii-Saab T; Lesinski GB
Gut; 2018 Feb; 67(2):320-332. PubMed ID: 27797936
[TBL] [Abstract][Full Text] [Related]
32. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer.
Chen K; Qian W; Jiang Z; Cheng L; Li J; Sun L; Zhou C; Gao L; Lei M; Yan B; Cao J; Duan W; Ma Q
Mol Cancer; 2017 Jul; 16(1):131. PubMed ID: 28738823
[TBL] [Abstract][Full Text] [Related]
33. c-Met-targeted near-infrared fluorescent probe for real-time depiction and dissection of perineural invasion and lymph node metastasis lesions in pancreatic ductal adenocarcinoma xenograft models.
Li D; Yang M; Liang M; Mei C; Lin Y; Yang F; Xiao Y; Chen Y; Wang F; Mao J; Su Z
Biomater Sci; 2021 Oct; 9(20):6737-6752. PubMed ID: 34254599
[TBL] [Abstract][Full Text] [Related]
34. Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging.
Tummers WS; Miller SE; Teraphongphom NT; Gomez A; Steinberg I; Huland DM; Hong S; Kothapalli SR; Hasan A; Ertsey R; Bonsing BA; Vahrmeijer AL; Swijnenburg RJ; Longacre TA; Fisher GA; Gambhir SS; Poultsides GA; Rosenthal EL
Ann Surg Oncol; 2018 Jul; 25(7):1880-1888. PubMed ID: 29667116
[TBL] [Abstract][Full Text] [Related]
35. Improvement of biodistribution profile of a radiogallium-labeled, αvβ6 integrin-targeting peptide probe by incorporation of negatively charged amino acids.
Nakamura S; Matsuno A; Ueda M
Ann Nucl Med; 2020 Aug; 34(8):575-582. PubMed ID: 32514725
[TBL] [Abstract][Full Text] [Related]
36. The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.
Hausner SH; Bauer N; Hu LY; Knight LM; Sutcliffe JL
J Nucl Med; 2015 May; 56(5):784-90. PubMed ID: 25814519
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer.
Kimura RH; Teed R; Hackel BJ; Pysz MA; Chuang CZ; Sathirachinda A; Willmann JK; Gambhir SS
Clin Cancer Res; 2012 Feb; 18(3):839-49. PubMed ID: 22173551
[TBL] [Abstract][Full Text] [Related]
39. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
[TBL] [Abstract][Full Text] [Related]
40. Engineered knottin peptide enables noninvasive optical imaging of intracranial medulloblastoma.
Moore SJ; Hayden Gephart MG; Bergen JM; Su YS; Rayburn H; Scott MP; Cochran JR
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14598-603. PubMed ID: 23950221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
